FDA Wants To See New, Improved Hospital Continuous Glucose Monitors
This article was originally published in The Gray Sheet
Executive Summary
FDA is encouraging industry to submit study designs for newer, more accurate continuous glucose monitors for hospital use. It gathered experts at a June 25 public meeting to discuss questions around indications for use and trial designs.
You may also be interested in...
New Products In Brief
Product approvals and launches from Cardiva, Medtronic and more.
Tight Glycemic Control: Critical Care’s Balancing Act
Over a decade ago, the New England Journal of Medicine published a study identifying tight glycemic control in the intensive care unit as a critical step to improving patient outcomes. Today, a small pack of companies is trying to finally deliver on the promise.
Tight Glycemic Control: Critical Care’s Balancing Act
Over a decade ago, the New England Journal of Medicine published a study identifying tight glycemic control in the intensive care unit as a critical step to improving outcomes. Today, GlySure and others are working on continuous glucose monitoring for the critical care environment to help deliver on that promise.